GOLDMAN SACHS GROUP INC - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 201 filers reported holding CANTEL MEDICAL CORP in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$48,893,000
+253.9%
612,388
+249.5%
0.01%
+200.0%
Q4 2020$13,817,000
+42.5%
175,208
-20.6%
0.00%
+33.3%
Q3 2020$9,694,000
-71.5%
220,620
-71.3%
0.00%
-70.0%
Q2 2020$34,040,000
+212.6%
769,609
+153.7%
0.01%
+150.0%
Q1 2020$10,891,000
-23.5%
303,373
+51.1%
0.00%0.0%
Q4 2019$14,238,000
-26.9%
200,816
-22.9%
0.00%
-33.3%
Q3 2019$19,484,000
-16.3%
260,479
-9.8%
0.01%
-14.3%
Q2 2019$23,289,000
+133.5%
288,800
+93.7%
0.01%
+133.3%
Q1 2019$9,975,000
-16.2%
149,124
-6.8%
0.00%
-25.0%
Q4 2018$11,907,000
-31.0%
159,941
-14.7%
0.00%0.0%
Q3 2018$17,259,000
-32.3%
187,480
-27.6%
0.00%
-42.9%
Q2 2018$25,484,000
+13.6%
259,094
+28.7%
0.01%
+16.7%
Q1 2018$22,436,000
+40.9%
201,382
+30.1%
0.01%
+50.0%
Q4 2017$15,918,000
-37.7%
154,733
-43.0%
0.00%
-42.9%
Q3 2017$25,563,000
+320.7%
271,461
+248.1%
0.01%
+250.0%
Q2 2017$6,076,000
-15.5%
77,993
-13.1%
0.00%0.0%
Q1 2017$7,190,000
-21.2%
89,758
-22.6%
0.00%
-33.3%
Q4 2016$9,128,000
-49.2%
115,918
-49.7%
0.00%
-40.0%
Q3 2016$17,983,000
+81.5%
230,599
+59.9%
0.01%
+66.7%
Q2 2016$9,909,000
+55.1%
144,190
+61.1%
0.00%
+50.0%
Q1 2016$6,389,000
+5.7%
89,525
-7.9%
0.00%0.0%
Q4 2015$6,042,000
+12.8%
97,239
+2.9%
0.00%0.0%
Q3 2015$5,357,000
-5.8%
94,472
-10.8%
0.00%0.0%
Q2 2015$5,685,000
-12.9%
105,924
-23.0%
0.00%0.0%
Q1 2015$6,530,000
+44.1%
137,480
+31.2%
0.00%
+100.0%
Q4 2014$4,533,000
+84.6%
104,790
+46.8%
0.00%0.0%
Q3 2014$2,455,000
+59.2%
71,384
+69.6%
0.00%
Q2 2014$1,542,000
-5.6%
42,098
-13.1%
0.00%
-100.0%
Q1 2014$1,633,000
-41.2%
48,417
-40.9%
0.00%0.0%
Q4 2013$2,778,000
+6.8%
81,925
+0.3%
0.00%0.0%
Q3 2013$2,601,000
+25.3%
81,667
+33.2%
0.00%0.0%
Q2 2013$2,076,000
+2.5%
61,301
-10.0%
0.00%0.0%
Q4 2012$2,025,000
+17.7%
68,103
+7.2%
0.00%0.0%
Q3 2012$1,720,000
+6.6%
63,529
+7.3%
0.00%0.0%
Q2 2012$1,614,00059,2160.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q3 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders